Slow and steady... good to see another Aussie pathology "giant" (Helius ($1.4B) working RHY, alongside Sonic ($9B) on ColoStat.
Key milestones are TGA approval and revenue this CY all of which seems achievable considering their reliability in hitting all key milestones to date.
GLTAH
Ann: RHY Advances Platform Expansion with Other Cancers, page-9
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.93M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 105000 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 68500 | 1 |
View Market Depth
| Last trade - 16.12pm 09/08/2024 (20 minute delay) ? |
| RHY (ASX) Chart |
Day chart unavailable